PL48393B1 - - Google Patents
Download PDFInfo
- Publication number
- PL48393B1 PL48393B1 PL97866A PL9786661A PL48393B1 PL 48393 B1 PL48393 B1 PL 48393B1 PL 97866 A PL97866 A PL 97866A PL 9786661 A PL9786661 A PL 9786661A PL 48393 B1 PL48393 B1 PL 48393B1
- Authority
- PL
- Poland
- Prior art keywords
- sodium carbonate
- acetylsalicylic acid
- acidic sodium
- acidic
- ruch
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 6
- 230000002378 acidificating effect Effects 0.000 claims 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 2
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- JZLOKWGVGHYBKD-UHFFFAOYSA-M sodium;2-acetyloxybenzoate Chemical compound [Na+].CC(=O)OC1=CC=CC=C1C([O-])=O JZLOKWGVGHYBKD-UHFFFAOYSA-M 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 206010036030 Polyarthritis Diseases 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- PCTXBFQNMDKOSP-UHFFFAOYSA-M sodium;(2-carboxyphenyl) sulfate Chemical compound [Na+].OS(=O)(=O)OC1=CC=CC=C1C([O-])=O PCTXBFQNMDKOSP-UHFFFAOYSA-M 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL48393B1 true PL48393B1 (pt) | 1964-06-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2659689A (en) | Benzoic esters | |
| US3160662A (en) | Lower alkylaminoacyl amide anesthetics | |
| PL48393B1 (pt) | ||
| GB938243A (en) | Stable preparations of alkali metal salts of estrone sulfate | |
| GB2146324A (en) | A carbocysteine salt | |
| US3072720A (en) | Novel n-arylsulfonyl-n'-(2, 5-endomethylene-1, 2, 5, 6-tetrahydrobenzyl) ureas | |
| Lauer et al. | The Piria Reaction. III. 1 Mechanism Studies2 | |
| US3089878A (en) | 3-alkyl-4-hydroxy-7-chlorocoumarin-6-sulfonamides | |
| GB925890A (en) | Drug/resin adsorbates and a process for the manufacture of same | |
| DE69312849T2 (de) | Mercapto-acetamid-derivate | |
| US2492710A (en) | Basic bismuth para amino benzoate | |
| US2510495A (en) | Therapeutic compositions | |
| Hasselstrom et al. | Reactions involved in the sulfonation of heat treated abietic acid | |
| KR850008619A (ko) | 니페디핀 조성물의 제조방법 | |
| US2864824A (en) | Alkoxy derivatives of 3:5-dioxo-pyrazolidene and process for their manufacture | |
| US1689696A (en) | Ester of salicylic acid and pyruvic acid | |
| US2796432A (en) | Alpha-(2, 4, 6-triiodophenoxy) butyric acid and its preparation | |
| US2751412A (en) | Nu-(hydroxyalkyl)-3-phenylsalicylamides | |
| CH268388A (de) | Verfahren zur Darstellung eines Urethans mit dem Ringsystem der Lysergsäure. | |
| US2464198A (en) | Process for preparing a chemical composition for water purification | |
| US2469967A (en) | Cyclopentano perhydrophenanthrene compounds | |
| US2467602A (en) | 2,3-bis-(benzamidomethylthio)-propanol | |
| CN105232508A (zh) | 一种组合物及其在预防或治疗胰腺纤维化药物中的应用 | |
| CS208184B2 (en) | Method of making the roentgen amorphous ascine | |
| US721923A (en) | Alkali caffeine methylene disalicylate. |